Marc G. Besselink
Dutch surgeon who leads the PREOPANC trials testing chemotherapy or chemoradiation before pancreatic cancer surgery.
Overview
Marc Besselink (Amsterdam UMC) leads the Dutch Pancreatic Cancer Group and was senior investigator of PREOPANC, the randomised trial showing neoadjuvant chemoradiotherapy improves long-term survival in resectable and borderline resectable pancreatic cancer, and of PREOPANC-2 comparing neoadjuvant FOLFIRINOX. He has led the DIPLOMA and LEOPARD trials of minimally invasive pancreatic surgery.
Pages like this
not linked directly; found by shared links- PersonPeter W. T. Pisters
Shares Robotic & minimally invasive surgery, Pancreatic ductal adenocarcinoma.
- PersonPedro T. Ramirez
Shares Robotic & minimally invasive surgery and the tag surgery.
- PersonArnaud Méjean
Shares Robotic & minimally invasive surgery and the tag surgery.
- PersonDaniel D. Von Hoff
Shares Pancreatic ductal adenocarcinoma and the tag pancreatic.
- PersonJonathan Spicer
Shares the tags surgery, neoadjuvant.
- PersonRavindra Uppaluri
Shares the tags surgery, neoadjuvant.
- PersonJulio Garcia-Aguilar
Shares Robotic & minimally invasive surgery and the tag surgery.
- PersonFreddie C. Hamdy
Shares Robotic & minimally invasive surgery and the tag surgery.